Health Condition 1: I831- Varicose veins of lower extremities with inflammation
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Subjects that are suffering from the Varicose veins 2.Subjects from 18 to 65 years of age. 3.If female with childbearing potential, must be willing to practice an acceptable form of birth control for the duration of the study. 4.Subjects that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study. 5.Subjects willing to avoid participation in any other interventional clinical trial for the duration of the study.
Exclusion criteria
Exclusion criteria: 1.Subjects that are pregnant, breast feeding, or planning to get pregnant during the study. 2.Subjects that have participated in any other interventional clinical trial in the previous 30 days. 3.Subjects with known sensitivity to any of the constituents of the investigational product.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Varicose vein calculated as VCSS ranging from 0-3 and CEAP. 2.Reduction in affected area. Timepoint: Baseline to Day 60 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Change in VAS score 2.Change in quality of life measured as SF 36Timepoint: Baseline to Day 60 | — |
Countries
India
Contacts
Mittal Global Clinical Trial Services